FDA Approved: TOBREX — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for TOBREX (tobramycin) submitted by Novartis Pharmaceuticals Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis
• Bacterial Keratitis

Drugs mentioned

• TOBREX (TOBRAMYCIN)

Snippet

SUPPL AP for TOBREX (TOBRAMYCIN)